2m 2m 2m 2m 2m 2m 2m
Geron (GERN)
NASDAQ
$0.99-$0.04 (-3.43%)
Price as of Nov 12, 2026 9:42 AM EST- $657.1MMarket Cap
- -17.74%1-Year Change
- BiotechnologyIndustry
Geron (GERN)
$0.99-$0.04 (-3.43%)
GERN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.02 | ||
Change | +$0.05 (+4.70%) | ||
Open | $0.98 | ||
High | $1.02 | ||
Low | $0.96 | ||
Previous Close | $0.97 | ||
Volume | 6,557,621 | ||
30-Day Average Volume | 16,379,173 | ||
1-Week Change | -5.56% | ||
1-Month Change | -16.73% | ||
1-Year Change | -17.74% | ||
3-Year Change | -41.38% | ||
5-Year Change | -33.33% | ||
Fundamentals | |||
Shares Outstanding | 644.2M | ||
Total Assets | $527.1M | ||
Market Cap | $657.1M | ||
Enterprise Value | $708.4M | ||
Period: QTR TTM FY | |||
Revenue | $60.1M | ||
Net Income | $1.4M | ||
Free Cash Flow | $10.3M | ||
EBIT | $5.8M | ||
EBITDA | $5.9M | ||
Net Working Capital | $394.5M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | 120 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | 64 | ||
Price/Operating Cash Flow | 64 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue